Adamas Pharmaceuticals: Return On Capital Employed Insights 2021-06-04T14:52:10-04:00June 4th, 2021| share this article! Adamas Pharmaceuticals (NASDAQ:ADMS) reported Q1 sales of $19.31 million. Earnings fell to a loss of $9.53 million, resulting in a 36.4% decrease from last quarter. Adamas… Read More share this article! Related Posts Wayfair Stock Leaps as Sales Beat Estimates and Customers Grow, Go to article May 2nd, 2024 Inside a $10 Billion Bet on the World’s Longest Heated Oil Pipeline in the ‘Pearl of Africa’, Go to article May 2nd, 2024 Peloton Stock Drops 13%. Its CEO Is Stepping Down and There Are Layoffs., Go to article May 2nd, 2024 DJT Stock Is Bouncing Back. Here’s Why., Go to article May 2nd, 2024
